Status toward the implementation of precision dosing in children
JS Barrett, RF Barrett, AA Vinks - The Journal of Clinical …, 2021 - Wiley Online Library
Precision dosing is progressing beyond the conceptual and proof‐of‐concept stages toward
implementation. As the availability of dosing algorithms, tools, and platforms increases, so …
implementation. As the availability of dosing algorithms, tools, and platforms increases, so …
Does “birth” as an event impact maturation trajectory of renal clearance via glomerular filtration? Reexamining data in preterm and full‐term neonates by avoiding the …
F Salem, TN Johnson, ABJ Hodgkinson… - The Journal of …, 2021 - Wiley Online Library
Glomerular filtration rate (GFR) is an important measure of renal function. Various models for
its maturation have recently been compared; however, these have used markers, which are …
its maturation have recently been compared; however, these have used markers, which are …
Population pharmacokinetics and dose optimization of vancomycin in neonates
The pharmacokinetics of vancomycin vary among neonates, and we aimed to conduct
population pharmacokinetic analysis to determine the optimal dosage of vancomycin in …
population pharmacokinetic analysis to determine the optimal dosage of vancomycin in …
Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing
Z Tang, J Guan, J Li, Y Yu, M Qian, J Cao… - International Journal of …, 2021 - Elsevier
Introduction Few studies incorporating population pharmacokinetic/pharmacodynamic (Pop-
PK/PD) modelling have been conducted to quantify the exposure target of vancomycin in …
PK/PD) modelling have been conducted to quantify the exposure target of vancomycin in …
Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy
Z Li, H Li, C Wang, Z Jiao, F Xu, H Sun - BMC Pharmacology and …, 2021 - Springer
Background We aim to develop a population pharmacokinetics (PopPK) model of
vancomycin for the treatment of septicemia in infants younger than one year. Factors …
vancomycin for the treatment of septicemia in infants younger than one year. Factors …
Dose tailoring of vancomycin through population pharmacokinetic modeling among surgical patients in Pakistan
MM Munir, H Rasheed, MI Khokhar, RR Khan… - Frontiers in …, 2021 - frontiersin.org
Background: Vancomycin is a narrow therapeutic agent, and it is necessary to optimize the
dose to achieve safe therapeutic outcomes. The purpose of this study was to identify the …
dose to achieve safe therapeutic outcomes. The purpose of this study was to identify the …
[HTML][HTML] Терапевтический лекарственный мониторинг ванкомицина у новорожденных: проблемы и перспективы
БЕ Толкачев, ВИ Петров, ТЕ Заячникова… - Лечебное …, 2021 - cyberleninka.ru
Ванкомицин является одним из наиболее часто назначаемых антибиотиков для
лечения тяжелых нозокомиальных инфекций у новорожденных. Эмпирическое …
лечения тяжелых нозокомиальных инфекций у новорожденных. Эмпирическое …
Vancomycin Treatment Management in Pediatric Patient Population
TH Tung - 2021 - hammer.purdue.edu
This research was to study the treatment and therapeutic drug monitoring of vancomycin,
one of the most prescribed antibiotics in pediatric intensive care units in US hospitals, from a …
one of the most prescribed antibiotics in pediatric intensive care units in US hospitals, from a …
[PDF][PDF] Vancomycin-Ototoxizität bei Frühgeborenen
JS Marißen - zhb.uni-luebeck.de
In Deutschland kommen jährlich mehr als 60.000 Frühgeborene–gemäß
Weltgesundheitsorganisation (WHO) als Geburt vor der vollendeten 37 …
Weltgesundheitsorganisation (WHO) als Geburt vor der vollendeten 37 …